BioHarvest Sciences Inc. Common Stock
BHST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $163,965 | $116,620 | $107,259 | $107,085 |
| - Cash | $10,966 | $3,727 | $3,401 | $2,390 |
| + Debt | $19,844 | $21,092 | $18,571 | $13,818 |
| Enterprise Value | $172,843 | $133,985 | $122,428 | $118,513 |
| Revenue | $9,067 | $8,515 | $7,860 | $7,278 |
| % Growth | 6.5% | 8.3% | 8% | – |
| Gross Profit | $5,570 | $5,086 | $4,595 | $4,123 |
| % Margin | 61.4% | 59.7% | 58.5% | 56.7% |
| EBITDA | -$535 | -$1,408 | -$1,320 | -$1,346 |
| % Margin | -5.9% | -16.5% | -16.8% | -18.5% |
| Net Income | -$2,513 | -$4,080 | -$2,338 | -$2,956 |
| % Margin | -27.7% | -47.9% | -29.7% | -40.6% |
| EPS Diluted | -0.14 | -0.24 | -0.13 | -0.17 |
| % Growth | 41.7% | -84.6% | 23.5% | – |
| Operating Cash Flow | -$2,114 | -$1,509 | -$1,427 | -$2,948 |
| Capital Expenditures | -$428 | -$615 | -$684 | -$345 |
| Free Cash Flow | -$2,542 | -$2,124 | -$2,111 | -$3,293 |